Literature DB >> 1730841

Exercise-induced asthma is not associated with mast cell activation or airway inflammation.

N N Jarjour1, W J Calhoun.   

Abstract

Exercise-induced asthma (EIA) may affect up to 90% of patients with asthma. Hyperpnea associated with exercise leads to increased airway water and heat loss, which contributes to the development of EIA. Measurement of circulating mediators has suggested that mast cells may participate in the development of EIA via release of histamine and neutrophil chemotactic factor. To evaluate further the contribution of pulmonary mast cell-mediator release in the pathogenesis of EIA and to determine whether EIA is associated with enhancement of airway inflammation, we studied 11 subjects with mild stable asthma (FEV1, 93% +/- 3% predicted; mean +/- SEM) with significant EIA (after exercise fall in FEV1, 41% +/- 5%). Bronchoalveolar lavage (BAL) was performed immediately (less than 1 hour) after exercise challenge (EC) and repeated 24 hours later (exercise studies). On another occasion, paired BALs were done 24 hours apart (control studies). A minimum of 2 weeks separated the exercise and control pairs. No changes were observed in BAL cell counts, differentials, or reactive oxygen species metabolism after EC. Neither BAL histamine nor BAL tryptase levels increased, either shortly (less than 1 hour) or 24 hours after EC. We conclude that EC in subjects with asthma is not associated with cellular influx to airspace and that mechanisms other than histamine release by pulmonary mast cells may be responsible for EIA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730841     DOI: 10.1016/s0091-6749(05)80041-7

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  9 in total

1.  Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis.

Authors:  L B Schwartz; T R Bradford; C Rouse; A M Irani; G Rasp; J K Van der Zwan; P W Van der Linden
Journal:  J Clin Immunol       Date:  1994-05       Impact factor: 8.317

Review 2.  Role of cells and mediators in exercise-induced bronchoconstriction.

Authors:  Teal S Hallstrand; William A Altemeier; Moira L Aitken; William R Henderson
Journal:  Immunol Allergy Clin North Am       Date:  2013-03-29       Impact factor: 3.479

Review 3.  New insights into pathogenesis of exercise-induced bronchoconstriction.

Authors:  Teal S Hallstrand
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-02

4.  Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist.

Authors:  T F Reiss; J B Hill; E Harman; J Zhang; W K Tanaka; E Bronsky; D Guerreiro; L Hendeles
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

5.  Inflammatory basis of exercise-induced bronchoconstriction.

Authors:  Teal S Hallstrand; Mark W Moody; Mark M Wurfel; Lawrence B Schwartz; William R Henderson; Moira L Aitken
Journal:  Am J Respir Crit Care Med       Date:  2005-06-09       Impact factor: 21.405

6.  Urinary excretion of 9α,11β-prostaglandin F2 and leukotriene E4 in patients with exercise-induced bronchoconstriction.

Authors:  Tae-Rim Shin; Joo-Hee Kim; Cheol-Hong Kim; In-Gyu Hyun; Jeong-Hee Choi
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

Review 7.  Exercise-induced asthma and anaphylaxis.

Authors:  D O Hough; K L Dec
Journal:  Sports Med       Date:  1994-09       Impact factor: 11.136

Review 8.  Etiology of exercise-induced asthma: physical stress-induced transcription.

Authors:  Thomas Hilberg
Journal:  Curr Allergy Asthma Rep       Date:  2007-04       Impact factor: 4.806

9.  Section 2. Exercise-Induced Bronchospasm: Albuterol versus Montelukast: Highlights of the Asthma Summit 2009: Beyond the Guidelines.

Authors:  Gene Colice; William J Calhoun
Journal:  World Allergy Organ J       Date:  2010-02-15       Impact factor: 4.084

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.